All In Biotech

Drug Trial Radar · NCT01328379

Study of Fampridine-ER Tablets in Patients With Multiple Sclerosis

Double-Blind, Placebo-Controlled, Parallel-Group Study to Evaluate the Safety and Efficacy of Two Doses of Oral Dalfampridine Extended Release Tablets (5 mg and 10 mg Twice Daily) in Patients With Multiple Sclerosis

Last checked: Nov 20, 2026Latest source record: Sep 5, 2013 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedResults posted on the registryPivotal-lookingPhase 3. Randomized with 430 participants. This is a heuristic, not a regulatory label.

Status

Completed

Enrollment

430

Actual

Start

Mar 2011

Primary completion

Apr 2012

Study completion Jul 2012

Sponsor

Lead sponsor
Acorda TherapeuticsIndustry
Sponsor type
Industry
First posted
Apr 4, 2011

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 3
Allocation
Randomized
Model
Parallel
Masking
Triple (participant, investigator, outcomes assessor)
Primary purpose
Treatment
Who can join
All sexes, from 18 years, up to 70 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The purpose of this study is to investigate the safety and efficacy of a lower dose of dalfampridine extended release tablets compared to the currently approved dose in improving walking in Multiple Sclerosis (MS) patients.

Conditions

  • Multiple Sclerosis

Interventions

  • Dalfampridine-ER 5mgDrug

    5mg, twice daily

  • Dalfampridine-ER 10mgDrug

    10mg, twice daily

  • PlaceboOther

    placebo, twice daily

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Change From Baseline in Walking Speed Near Maximum Plasma Concentration at Steady State (CmaxSS) of Placebo and Dalfampridine-ER (5mg and 10mg), Using the Timed 25 Foot Walk (T25FW).Time frame: Baseline Visit 1 (double-blind study day 1) and approximately 3-4 hours post dose at Visit 3 (end of double-blind week 4)

Locations

70 sites in 1 country. Site status is shown where the registry gives one.

  • North Central Neurology Associates, PC

    Cullman, Alabama

  • Phoenix Neurological Associates, Ltd

    Phoenix, Arizona

  • Arizona Neurological Institute

    Sun City, Arizona

  • Clinical Research Advantage Inc.

    Tempe, Arizona

  • Sutter East Bay Physicians Medical Foundation

    Berkeley, California

  • Neuro-Pain Medical Center, Inc.

    Fresno, California

  • Loma Linda University Medical Center

    Loma Linda, California

  • Collaborative NeuroScience Network, Inc.

    Long Beach, California

  • University of California Davis Medical Center

    Sacramento, California

  • Mount Sinai Rehabilitation Hospital

    Hartford, Connecticut

  • Georgetown University Hospital

    Washington D.C., District of Columbia

  • Neurology Associates, PA

    Maitland, Florida

  • University of Miami School of Medicine, Dept. of Neurology

    Miami, Florida

  • Neurological Associates

    Pompano Beach, Florida

  • Neurologique Foundation, Inc.

    Ponte Vedra, Florida

  • Negroski, Sutherland and Hanes Neurology

    Sarasota, Florida

  • Suncoast Neuroscience Associates, Inc.

    St. Petersburg, Florida

  • Tallahassee Neurological Clinic, PA

    Tallahassee, Florida

  • Axiom Clinical Research of Florida

    Tampa, Florida

  • The Multiple Sclerosis Center of Vero Beach

    Vero Beach, Florida

  • Sheperd Center, Inc.

    Atlanta, Georgia

  • Northwestern University

    Chicago, Illinois

  • Consultants in Neurology Ltd.

    Northbrook, Illinois

  • Indiana University School of Medicine

    Indianapolis, Indiana

  • Josephson Wallack Munshower Neurology, PC

    Indianapolis, Indiana

  • Methodist Plaza Specialty

    Des Moines, Iowa

  • Ruan Neurology Clinic and Research Center

    Des Moines, Iowa

  • The University of Kansas Medical Center

    Kansas City, Kansas

  • Associates in Neurology, PSC

    Lexington, Kentucky

  • University of Maryland, Maryland Center for Multiple Sclerosis

    Baltimore, Maryland

  • Lahey Clinic

    Lexington, Massachusetts

  • Springfield Neurology Associates, LLC

    Springfield, Massachusetts

  • Wayne State University

    Detroit, Michigan

  • Advanced Neurology Specialists

    Great Falls, Montana

  • Veterans Administration Sierra Neveda Health Care System

    Reno, Nevada

  • Upstate Clinical Research, LLC

    Albany, New York

  • NYU Langone Medical Center MS Comprehensive Care Center

    New York, New York

  • Comprehensive Multiple Sclerosis Care Center at South Shore Neurologic Associates

    Patchogue, New York

  • Island Neurological Associates, PC

    Plainview, New York

  • University of Rochester Medical Center

    Rochester, New York

Showing 40 of 70 sites, US sites first. The full list is on the registry record.

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.